These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10419600)

  • 1. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
    Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
    J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
    Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
    Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of MUC2 synthesis in ulcerative colitis.
    Tytgat KM; van der Wal JW; Einerhand AW; Büller HA; Dekker J
    Biochem Biophys Res Commun; 1996 Jul; 224(2):397-405. PubMed ID: 8702401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
    Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
    Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease.
    Krishna M; Woda B; Savas L; Baker S; Banner B
    Mod Pathol; 1995 Aug; 8(6):654-7. PubMed ID: 8532700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.
    Van der Sluis M; De Koning BA; De Bruijn AC; Velcich A; Meijerink JP; Van Goudoever JB; Büller HA; Dekker J; Van Seuningen I; Renes IB; Einerhand AW
    Gastroenterology; 2006 Jul; 131(1):117-29. PubMed ID: 16831596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
    Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH; Olsen JE; Jain S; Doe WF
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
    Yantiss RK; Das KM; Farraye FA; Odze RD
    Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
    Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
    J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
    Katsuta T; Lim C; Shimoda K; Shibuta K; Mitra P; Banner BF; Mori M; Barnard GF
    Am J Gastroenterol; 2000 Nov; 95(11):3157-64. PubMed ID: 11095335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopsy histamine in ulcerative colitis and Crohn's disease.
    Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
    Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
    Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH
    Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis.
    Li D; Wang D; Majumdar S; Jany B; Durham SR; Cottrell J; Caplen N; Geddes DM; Alton EW; Jeffery PK
    J Pathol; 1997 Mar; 181(3):305-10. PubMed ID: 9155717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
    J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.